TherapeuticsMD (TXMD) Change in Receivables (2010 - 2022)
TherapeuticsMD's (TXMD) quarterly Change in Receivables came in at -$13.6 million in Q3 2022, down 439.82% YoY from $4.0 million in Q3 2021, and down 223.03% on a QoQ basis from $11.1 million in Q2 2022.
TherapeuticsMD (TXMD) Change in Receivables (2010 - 2022) Analysis & Trends
TherapeuticsMD (TXMD) has 13 years of Change in Receivables data on file, last reported at -$13.6 million in Q3 2022.
- Quarterly Change in Receivables fell 439.82% year-over-year to -$13.6 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was -$4.3 million (down 130.19% YoY) and the FY2021 annual result came in at $4.3 million, down 47.39% from the prior year.
- Change in Receivables eased to -$13.6 million in Q3 2022, from $11.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $11.1 million in Q2 2022 to a low of -$13.6 million in Q3 2022.
- A 5-year average of $1.6 million and a median of $790885.0 in 2018 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2018 — Change in Receivables plunged 2767.32% — and 2022, when it soared 48326.09%.
- Tracing TXMD's Change in Receivables over 5 years: stood at -$1.8 million in 2018, then jumped by 629.91% to $9.3 million in 2019, then retreated by 7.4% to $8.6 million in 2020, then slumped by 114.32% to -$1.2 million in 2021, then tumbled by 1006.81% to -$13.6 million in 2022.
- The last three Change in Receivables figures came in at -$13.6 million (Q3 2022), $11.1 million (Q2 2022), and -$489000.0 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.67 Mn | 14.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -13.65 Mn |
| Sep 30, 2022 | -13.65 Mn |
| Jun 30, 2022 | 11.09 Mn |
| Jun 30, 2022 | 11.09 Mn |
| Mar 31, 2022 | -489,000.00 |
| Mar 31, 2022 | -489,000.00 |
| Dec 31, 2021 | -1.23 Mn |
| Dec 31, 2021 | -1.23 Mn |
| Sep 30, 2021 | 4.02 Mn |
| Sep 30, 2021 | 4.02 Mn |
| Jun 30, 2021 | -23,000.00 |
| Jun 30, 2021 | -23,000.00 |
| Mar 31, 2021 | 1.57 Mn |
| Mar 31, 2021 | 1.57 Mn |
| Dec 31, 2020 | 8.61 Mn |
| Dec 31, 2020 | 8.61 Mn |
| Sep 30, 2020 | 5.90 Mn |
| Sep 30, 2020 | 5.90 Mn |
| Jun 30, 2020 | -2.43 Mn |
| Jun 30, 2020 | -2.43 Mn |